Veradigm (NASDAQ:MDRX) Sees Large Volume Increase – Still a Buy?

Veradigm Inc. (NASDAQ:MDRX – Get Free Report) saw strong trading volume on Monday. Approximately 498,926 shares changed hands during trading, an increase of 321% from the previous session’s volume of 118,634 shares. The stock last traded at $4.80 and had previously closed at $4.95.

Veradigm Price Performance

The firm has a 50-day simple moving average of $4.89 and a 200 day simple moving average of $4.82. The company has a market capitalization of $580.92 million, a PE ratio of 23.25 and a beta of 0.51.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc (NASDAQ:MDRX), formerly known as Allscripts Healthcare Solutions, is a healthcare technology company that provides software, data and connectivity solutions for healthcare organizations, physicians, patients, payers and life sciences companies. The company changed its name to Veradigm in 2023 to reflect its broader focus on using healthcare data to support clinical, operational and commercial decision-making.

Veradigm’s offerings include electronic health record and practice-management solutions, electronic prescribing, revenue-cycle and financial management tools, patient engagement services and healthcare information-exchange capabilities.

Further Reading

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.